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Abstract: Due to the ever-increasing burden of antimicrobial-resistant (AMR) bacteria, the develop-
ment of novel antimicrobial agents and biomaterials to act as carriers and/or potentiate antimicrobial
activity is essential. This study assessed the antimicrobial efficacy of the following ionic metals, silver,
gold, palladium, platinum, zinc, and gallium alone and in combination with graphene matrices
(which were coated via a drop casting coating method). The graphene foam was utilized as a carrier
for the ionic metals against both, antibiotic susceptible and resistant bacterial strains of Acinetobac-
ter baumannii, Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa. Ionic gold,
palladium and platinum demonstrated the greatest antimicrobial activity against the susceptible
and resistant strains. Scanning electron microscopy (SEM) visualized cellular ultrastructure damage,
when the bacteria were incubated upon the graphene foam alone. This study suggests that specific
metal ions applied in combination with graphene foam could present a potential therapeutic option
to treat AMR bacterial infections. The application of the graphene foam as a potential carrier could
promote antimicrobial activity, provide a sustained release approach and reduce possible resistance
acquisition. In light of this study, the graphene foam and ionic metal combinations could potentially
be further developed as part of a wound dressing.
Keywords: metal ions; graphene; antibiotic resistance; foams; biomaterials
1. Introduction
Healthcare-associated infections (HAIs) are a substantial burden on healthcare settings
worldwide. The emergence of multidrug resistant (MDR) bacterial strains has further
exacerbated this problem, resulting in serious financial burdens on healthcare services [1–3].
The lack of effective antimicrobial therapies to combat MDR bacterial strains has led to an
urgent need to develop alternative therapeutic options [4].
It is estimated that in developed countries chronic wounds occur in around 2 % of the
population [5]. Delayed wound healing can lead to both local and systemic complications
such as bacteraemia, osteomyelitis, sepsis and ultimately death [6]. Wound dressings play
a pivotal role in the management of wound healing. The use of antimicrobial agents within
the dressing structure, such as silver sulfadiazine, has been previously associated with a
positive outcome, resulting in a reduction in bacterial infections [7]. Other wound dressings
such as those which incorporate silver nanoparticles can also promote cellular proliferation
and therefore wound healing, whilst maintaining high levels of antimicrobial efficacy [8,9].
Modern examples of metals utilised as therapeutic agents include cisplatin-based
anti-cancer drugs, anti-arthritis drugs and topical antimicrobials (such as zinc salts) [10].
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Different metal-based compounds have distinct structural configurations (e.g., ions, oxides
and nanoparticles) which exhibit different mechanisms of antimicrobial action. The most
common mechanisms of action however include, cellular ultrastructure damage via oxida-
tive stress, membrane damage and protein dysfunction. Importantly, the application of
metals as antimicrobial agents may result in a reduced probability of resistance occurrence;
in contrast to many antibiotics, metals target multiple components of the bacterial cell,
simultaneously [11–13].
Graphene is defined as a two-dimensional (2D) monolayer lattice of sp2 hybridised
carbon atoms [14–16]. Graphene has unique properties such as excellent thermal and
electrical conductivity, permeability to gasses, excellent tensile strength and it can be readily
chemically functionalized, such properties have resulted in a plethora of applications [17].
Since its discovery in 2004, graphene and its derivatives, have been the focus of numerous
research groups for a myriad of applications including electrochemistry (e.g., electrodes,
sensors and supercapacitors), drug delivery (graphene-based drug carriers), dental fillers,
water/surface disinfection and antimicrobial activity [18–23].
Antimicrobial properties have been demonstrated by graphene and its derivatives [24].
Graphene is believed to perturb the bacterial cytoplasmic membrane, due to the insertion
of sharp graphene edges, leading to the loss of membrane integrity, resulting in cell
lysis and death [25]. Other proposed antimicrobial mechanisms of graphene include
wrapping, oxidative stress (with and without reactive oxygen species (ROS) production),
lipid bilayer extraction and interference of protein-protein interactions [19,22]. Wrapping by
graphene occurs when the microorganism is surrounded by graphene and nutritional and
physicochemical conditions are altered [26]. Previously, simulations have demonstrated
that graphene sheets > 5.20 nm could partially wrap around a bacterial species, resulting
in the inversion of the phospholipid bilayer whilst, graphene sheets < 5.20 nm could
penetrate the cell membrane [27]. A recent study conducted in 2020 by Butler et al.,
revealed that graphene derivatives (graphite, graphene and graphene oxide) potentiated
the activity of antibiotics (ciprofloxacin, chloramphenicol and piperacillin/tazobactam)
against Enterococcus faecium, Klebsiella pneumoniae and Escherichia coli [28].
Due to the increasing prevalence of MDR pathogens and scarcity of novel effective
antibiotics, there has been very few major classes of broad-spectrum antibiotics developed
over the last 40 years [29]. However, teixobactin, which was first discovered in 2015
is an effective antimicrobial agent against S. aureus and Mycobacterium tuberculosis; this
antibiotic inhibits cell wall synthesis by binding to a highly conserved motif of lipid II
(a precursor of peptidoglycan) and lipid III (a precursor of cell wall teichoic acid) [30].
Whilst, recent research conducted by Picconi et al., (2020) may have discovered a new broad-
spectrum antibiotic class in the form of modified pyrrolobenzodiazepines with a C8-linked
aliphatic heterocycle [31]. This novel broad-spectrum antibiotic class demonstrated potent
antimicrobial activity against MDR Gram-negative bacteria [31]. Whilst the emergence of
new broad-spectrum antibiotics is promising, alternative therapies antimicrobial therapies
must also be considered in order to effectively treat MDR infections. The utilisation of
metals and graphene-based compounds may be one potential avenue to explore in order
to alleviate the burden placed on traditional therapeutic options. Furthermore, the use
of metal ions in combination with graphene (in this instance graphene coated with ionic
metals to act as a carrier) could potentially promote antimicrobial activity, therefore acting
as an alternative wound dressing treatment.
This study aimed to investigate the antimicrobial activity of metal ions in combination
with graphene foams via a drop cast coating method in order to determine the antimicrobial
efficacy, whilst demonstrating the efficacy of the graphene foams as therapeutic carriers
against a range of antibiotic susceptible and resistant bacteria.
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2. Materials and Methods
2.1. Bacterial Strains
Four susceptible bacterial isolates, Staphylococcus aureus strain NCTC 12973, Klebsiella
pneumoniae strain NCTC 9633, Acinetobacter baumannii strain NCTC 12156 and Pseudomonas
aeruginosa strain NCTC 10332 and four resistant isolates, S. aureus hospital isolate 252, K.
pneumoniae hospital isolate 1411061, A. baumannii isolate A483 and Pseudomonas aeruginosa
strain VTK106689 were originally sourced from Leeds General Infirmary, UK. All strains
were cultured on Tryptone Soya agar (TSA) or broth (TSB) and incubated for 24 h at 37 ◦C
unless stated otherwise. Before experimentation all strains were characterised for antibiotic
resistance using both Gram-positive and Gram-negative/urine MASTRING-S® (Gram-
positive: M13/NCE, Gram-negative/Uropathogens M26/NCE, Mast Group, Merseyside,
UK). Briefly, 100 µL of bacterial suspension (optical density (OD) 1.0 (±0.1) at 540 nm)
was spread onto TSA and incubated at 37 ◦C for 18 h. The normalisation of the OD
540 nm resulted in bacterial concentrations of ca. 5.0 × 108 CFU mL−1. Negative controls
(containing no bacteria) were included to confirm sterility (data not shown). Following
incubation, zones of inhibition (ZoIs) were measured using digital calipers accurate to three
decimal places, in order to determine antibiotic resistance profiles. Two bacterial isolates
were included for each bacterial species, the bacterial strain that demonstrated the greatest
ZoI for all relevant antibiotics (e.g., S. aureus and common Gram-positive antibiotics) was
catergorised as susceptible, whilst the other was deemed resistant.
2.2. Graphene Foam Preparation
Three-dimensional multilayer graphene foam was procured from Graphene-Supermar
ket, USA and sections were prepared using a sterile cork-borer (7 mm diameter) and then
sterilised for 2 h under UV light at 375 nm prior to experimentation. A drop cast method
was used to incorporate the metal ions into the graphene foam. Aliquots of 20 µL of the
test metal ion/acid (as described in the following section, “test compounds”) were added
directly to the surface of the graphene foam and left at room temperature for 30 min prior
to experimentation.
2.3. Test Compounds
The metal ions evaluated in this study, silver, gold, palladium, platinum, zinc and
gallium, were Atomic Absorption Standards (AAS) at a concentration of ca. 1000 µg mL−1
(1000 ppm) and were used without further modification (Merck, Feltham, UK). The solvents
used to solubilise the metal ions were tested individually throughout this study and results
were subtracted, in order to assure the antimicrobial effects observed were from the metal
ions alone. Graphene foams (Graphene Supermarket, Reading, MA, USA) were also
evaluated individually and in combination with the aforementioned metals.
2.4. Disc Diffusion Assays
The metal ions were evaluated individually and in combination with graphene foam
(via a drop cast coating method) to determine their antimicrobial efficacy against the bacte-
rial isolates. Bacterial strains were inoculated into TSB and incubated for 24 h at 37 ◦C with
agitation (150 rpm). Overnight cultures were then adjusted to an OD of 1.0 (±0.1) at 540 nm.
One hundred microliters of the adjusted suspension were inoculated onto a sterile TSA
plate and spread to establish confluency. The graphene foams (pre-coated with metal ions)
were then transferred to the centre of the inoculated agar plate. The antimicrobial activity
of the metal solutions/acid controls in the absence of graphene was also evaluated by
adding 20 µL of each of the metal ion solutions onto a sterile filter paper (6 mm diameter),
this was placed into the centre of the inoculated agar. All plates were incubated at 37 ◦C
for 24 h and zone of inhibition (ZoI) was established by measuring the inhibition diameter,
using digital callipers accurate to 0.001 mm. This experiment was performed in triplicate
from three independent starting cultures. Note, that the ZoI of the metal solution was
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subtracted from the ZoI of its corresponding metal ion to account for any antimicrobial
effect of the acid.
2.5. Scanning Electron Microscopy
Scanning electron microscopy (SEM) was used to visualise the bacterial cells post-
incubation with the graphene foam to determine if damage to the cellular ultrastructure
was a potential mechanism of action. Following incubation upon silicon wafers or graphene
foam (24 h at 37 ◦C), samples were dried at room temperature in a Class 2 biosafety cabinet
(Atlas Clean Air, Preston, UK). The samples were prepared as per Butler et al. (2020) [32].
Briefly, the samples were fixed in 4% v/v glutaraldehyde for 24 h at 4 ◦C. Once fixed the
samples were rinsed with sterile deionized water and subjected to an ethanol gradient,
10%, 30%, 50%, 70%, 90% and 100% v/v absolute ethanol. The samples were then stored
in a desiccator over 24 h to remove any moisture and were the sputter coated with gold
for 30 s (Polaron, London, UK) using the following parameters (power 5 mA, 30 s, 800 V,
vacuum 0.09 mbar, argon gas). Scanning electron microscopy (SEM) was then performed
using a JEOL (Tokyo, Japan) JSM-5600LV model SEM.
2.6. Statistical Analysis
Graphs were generated using Prism (Graphpad Software; version 8.4.3). The standard
error of the mean (SEM) was denoted via error bars. For statistical analysis, p values were
calculated at the 95 % confidence level by two-way ANOVAs, this was determined using
Graphpad Prism (version 8). In all cases, p < 0.05 was considered statistically significant.
Asterisks denote significance, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 and **** p ≤ 0.0001.
3. Results
3.1. Antibiotic Susceptibility Profiles
The antibiotic susceptibility of the susceptible and resistant bacterial strains was
determined against common broad-spectrum antibiotics that demonstrate antimicrobial
activity against both Gram-positive (Figure 1A,B) and Gram-negative (Figure 2A,B) bacteria.
When the antibiotics commonly utilised against Gram-positive bacteria were tested, S.
aureus was the most susceptible strain, with eight out of eight antibiotics inhibiting the
growth of this strain (NCTC 12973), whilst five out of the eight antibiotics (chloramphenicol,
fusidic acid, novobiocin, streptomycin and tetracycline) resulted in growth inhibition of the
resistant strain (Strain 252). The greatest inhibition of growth observed was by 10 µg fusidic
acid against the resistant strain (Strain 252), producing an average ZoI of 32.57 mm. The
least affected bacterial species to the commonly utilised antibiotics against Gram-positive
bacteria was A. baumannii with only tetracycline producing a ZoI (16.90 mm) against the
susceptible strain (NCTC 12156).
The MASTRING-S® antibiotics (M26/NCE) which are commonly utilised against
urinary tract pathogens/Gram-negative bacteria were tested against the susceptible and
resistant bacterial strains (Figure 2A,B). The growth of the susceptible strains, S. aureus
(NCTC 12973) and K. pneumoniae (NCTC 9633) was the most affected with both exhibit-
ing growth inhibition when tested against seven of the eight antibiotics. The largest ZoI
(26.80 mm) was determined by 10 µg tetracycline against the susceptible S. aureus strain.
The resistant bacterial strains demonstrated greater resistance profiles; five out of the eight
antibiotics inhibited S. aureus (Strain 252) growth, whilst three of the eight inhibited K. pneu-
moniae (Strain 1411061). The antibiotic which demonstrated the greatest growth inhibition
observed was 10 µg tetracycline (31.30 mm) produced against the resistant S. aureus (Strain
252). Overall, the most resistant strains utilised throughout this study were the resistant A.
baumannii (LMDR A483) strain, with only two of the fourteen antibiotics inhibiting growth,
and P. aeruginosa (VTK 106689) with only three antibiotics producing a ZoI. European Com-
mittee on Antimicrobial Susceptibility Testing (EUCAST) guidelines [33] were consulted to
determine antimicrobial susceptibility (Electronic Supplementary Information, Table S1).
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3.2. Disc Diffusion Assays
Metal Ions Alone and Graphene Alone
Overall, palladium and gold displayed the greatest antimicrobial efficacy against
the eight susceptible and resistant isolates tested (Figure 3). Both metals were able to
inhibit the growth of most of the isolates producing ZoIs in the range of 14.10–19.53 mm
and 15.14–17.68 mm against the susceptible isolates, and 12.73 mm–14.21 mm and 12.17–
13.877 mm against the resistant strains, with palladium and gold, respectively. Silver,
zinc and platinum similarly showed, good antimicrobial activity against the majority
of the isolates (Figure 3A,B). The degree of antimicrobial activity by the metals tested
observed was greater against the susceptible bacterial strains when compared to the
resistant strains. Gallium exhibited the least antimicrobial activity of the metals tested
against the bacterial isolates tested (Figure 3A,B). Interestingly, on average the metals
produced greater inhibition of growth against the susceptible bacterial strains. Graphene
exhibited the least antimicrobial activity producing ZoIs in the range of 7.00–7.78 mm for
the susceptible strains and 7.82 mm–8.36 mm for the resistant strains.




Figure 3. Zone of Inhibition determined by the metal ions and graphene alone against a range of (A) susceptible and (B) 
resistant bacteria (n = 3) * p ≤ 0.05. 
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To assess potentially synergistic activity of the metal ions when incorporated with 
graphene matrixes, zone of inhibition assays were conducted (Figure 4). In these assays, 
the graphene foam was used as a carrier for the metal ions. The antimicrobial efficacy 
demonstrated was similar to the metal ions tested alone, this indicated that the graphene 
did not have an antagonistic effect (Figure 3). Against the susceptible bacterial strains 
ionic silver in the presence of graphene demonstrated increased activity against S. aureus 
(14.60 mm; Figure 4A). Whilst, ionic platinum demonstrated slight synergistic activity 
with the graphene foams against the susceptible strains, producing enhanced ZoIs against 
Figure 3. Zone of Inhibition determined by the metal ions and graphene alone against a range of (A) susceptible and
(B) resistant bacteria (n = 3) * p ≤ 0.05.
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3.3. Metal Ions and Graphene in combination with Graphene Foam
To assess potentially synergistic activity of the metal ions when incorporated with
graphene matrixes, zone of inhibition assays were conducted (Figure 4). In these assays,
the graphene foam was used as a carrier for the metal ions. The antimicrobial efficacy
demonstrated was similar to the metal ions tested alone, this indicated that the graphene
did not have an antagonistic effect (Figure 3). Against the susceptible bacterial strains
ionic silver in the presence of graphene demonstrated increased activity against S. aureus
(14.60 mm; Figure 4A). Whilst, ionic platinum demonstrated slight synergistic activity with
the graphene foams against the susceptible strains, producing enhanced ZoIs against A.
baumannii (14.17 mm), K. pneumoniae (13.88 mm) and P. aeruginosa (14.46 mm) (Figure 4A).
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The ZoI assays combining the metal ions with the graphene foam was then conducted
with the resistant bacterial strains (Figure 4B). Overall, the addition of the metal ions to the
graphene foams resulted in similar antimicrobial activity as observed by the metal ions
alone, with no detriment to antimicrobial efficacy observed, against both the susceptible
and resistant bacterial strains.
3.4. Scanning Electron Microscopy
To visualise the effect of the graphene foams on the cellular ultrastructure of the
bacterial strains, SEM was conducted. Firstly, the structure of the graphene foam was
visualised at a low (×80) and higher magnification (×5000) (Figure 5). At a lower magnifi-
cation, a rough surface topography was observed with pits which were larger than single
microbial cell dimensions, this indicates that the bacteria could become entrapped in the
graphene structure.
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Figure 5. Scanning electron microscopy (SEM) images of (A) low (×80) and (B) high (×5000)
magnification of graphene foam.
The bacterial strains were incubated for 24 h (at 37 ◦C) on both silicon wafers and
graphene foams, the morphology of the resistant bacterial cells was then visualised
(Figure 6). The cells incubated on the silicon wafers were used as the control to effec-
tively compare against S. aureus, K. pneumoniae, A. baumannii and P. aeruginosa (Figure 6A,
6B, 6C and 6D, respectively) incubated on the graphene foams. Following incubation on
the graphene foam (Figure 6E), S. aureus was compared against the bacteria incubated on
silicon wafers (Figure 6A), cellular debris was observed in the presence of the graphene
foams (Figure 6F and 6G), whilst, some bacterial cells had developed pertusions through
the cellular membrane (Figure 6E), which were not evident in the control bacterial sample.
With the Gram-negative bacterial species, there was less of a pronounced effect observed,
except for with the K. pneumoniae and A. baumannii cells (Figure 6F,G). When incubated on
the graphene foams the A. baumannii cells are much smaller than the control which could
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indicate cellular leakage. The K. pneumoniae cells demonstrated a similar morphology to
the A. baumannii cells when incubated on graphene foams (Figure 6F). The P. aeruginosa
cells were largely unaffected by incubation with the graphene foams (Figure 6H).




Figure 6. Comparison of the bacteria on (A–D) silicon and (E–H) graphene foam demonstrating 
the changes in the bacterial morphology against the resistant strains (A,E) S. aureus (B,F) K. pneu-
moniae (C,G) A. baumannii (D,H) P. aeruginosa. 
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The emergence of AMR has resulted in enhanced morbidity and mortality rates, 
which in turn results in longer hospital stays, thus placing a financial burden on healthcare 
services worldwide [34–36]. There is currently a lack of effective therapies to combat AMR 
infections [4], if this is not addressed it has been proposed that that by 2050, AMR infection 
Figure 6. Comparison of the bacteria on (A–D) silicon and (E–H) graphene foam demonstrating the
changes in the bacterial morphology against the resistant strains (A,E) S. aureus (B,F) K. pneumoniae
(C,G) A. baumannii (D,H) P. aeruginosa.
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4. Discussion
The emergence of AMR has resulted in enhanced morbidity and mortality rates, which
in turn results in longer hospital stays, thus placing a financial burden on healthcare ser-
vices worldwide [34–36]. There is currently a lack of effective therapies to combat AMR
infections [4], if this is not addressed it has been proposed that that by 2050, AMR infection
will supersede cancer as the leading cause of mortality worldwide [37]. One potential av-
enue to be explored is the use of metal ions as alternative therapeutic options [19,36,38,39].
The utilization of graphene has grown rapidly in the last decade due to the unique prop-
erties of graphene and its derivatives, such materials have been widely explored for use
as potential biomaterials [40–43]. Throughout this study, six metal ions, silver, gold, palla-
dium, platinum, zinc and gallium were evaluated against susceptible and resistant bacterial
strains, S. aureus, A. baumannii, K. pneumoniae and P. aeruginosa. Furthermore, the metal
ions were tested individually and as part of a coated graphene combination to determine if
this had an effect on the antimicrobial activity observed.
The bacterial strains were firstly evaluated in regard to their antibiotic resistance
profiles and categorized as either susceptible or resistant in order to determine if the
metal ions could be utilized to eradicate AMR bacterial strains. Antimicrobial resistant
bacterial strains are becoming increasingly difficult to treat with some current treatment
options become largely ineffective. In a previous study conducted by Vaidya et al., (2017),
disc diffusion assays were conducted using silver, platinum, gold and palladium ions
against K. pneumoniae strain NCTC 9633 and A. baumannii strain NCTC 12156 [44]. In
contrast to the work presented in this previous study, the results in the current study
showed some differences in antimicrobial efficacy, this may be due to the different growth
media and conditions utilised [44,45]. However, unlike Vaidya et al., the current study
incorporated ionic metals with graphene foam in order to determine if this potentiated
the antimicrobial activity. When tested alone, gold and palladium ions produced the
greatest growth inhibition, although when tested in combination with the graphene foam
(where the graphene is coated with the metal ions via a drop cast method), silver and
platinum ions were as effective as gold and palladium. The combination of graphene
foam with palladium ions resulted in synergistic antimicrobial activity against the resistant
bacterial strains.
The antimicrobial properties of metals have been used throughout medical history [46].
The use of metals as antimicrobial agents declined after the discovery of antibiotics. How-
ever, due to the emergence of AMR there is a lack of effective therapeutic options [47].
Therefore, there has been a revival in the application of metals as biocidal agents [13,48]. The
antimicrobial action of metals begins with the affinity of metal ions towards cellular compo-
nents and biomolecules, which form stable complexes and damage vital bacterial cell pro-
cesses [49]. Metals demonstrate toxic effects in several ways, such as displacement/damage
of essential enzymes, blocking vital biomolecule functional groups or participating in cellu-
lar chemical reactions [13]. One or more of these processes may damage proteins, denature
DNA, induce oxidative stress or affect the biological walls/membranes [13]. Usually, met-
als demonstrate more than one antimicrobial mechanism of action, simultaneously. Such
antimicrobial mechanisms include, generation of ROS, the depletion of antioxidants, the
metal ions can also bind to the thiol groups of DNA, enzymes and proteins [13,50–52];
which results in cellular membrane damage, disruption of electron transport and inhibit
nutrient acquisition—resulting in cell lysis and ultimately death [53,54].
The antimicrobial activity of graphene and its derivatives remains controversial and
further research is required to elucidate the antimicrobial mechanisms of action [23]. Pre-
vious studies suggest that the antimicrobial action of graphene extends to multi-drug
resistant bacterial strains [38,55]. Karaky et al., (2020) previously determined that graphene
(MIC: 125 µg mL−1) and graphene oxide (MIC: >500 µg mL−1) procured from the same
source (Graphene Supermarket, USA) demonstrated little antimicrobial activity against a
range of P. aeruginosa hospital isolates [38]. In a previous study, the antimicrobial activity
of graphene was visualized using SEM, the presence of graphene sheets resulted in the
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loss of cell wall integrity in E. coli cells, resulting in cell death [56]. In the current study,
SEM analysis revealed similar cellular ultrastructure damage to S. aureus, K. pneumoniae
and A. baumannii.
The graphene foam used throughout this study has previously been characterised
by Brownson et al., 2013 [57]. Raman spectroscopy revealed two characteristic peaks at
ca. 1581 and 2684 cm−1 which are due to the G and 2D (G′) bands respectively; the highly
symmetrical 2D band and the intensity ratio of the G to 2D band indicate that the surface is
comprised of mono- to few-layer graphene sheets [57]. Furthermore, X-ray photoelectron
spectroscopy (XPS) revealed the graphene foam comprised 95 % carbon and 5 % oxygen,
whilst contact angle measurements revealed that the graphene foams exhibited a value of
120◦, which indicated quasi-super-hydrophobicity [57].
Ionic gold, palladium and platinum demonstrated the greatest antimicrobial activity
against the susceptible and resistant strains. Ionic gold like ionic silver, has a broad-
spectrum of antimicrobial activity, reacting with carboxyl-, phosphate- and amino-groups,
whilst also reducing the activity of lactate dehydrogenase [58,59]. The antimicrobial effect of
platinum ions has been well documented since the discovery of cisplatin [Pt(II) (NH3)2Cl2]
by Barnett Rosenberg in 1965. Rosenburg et al., 1965 were interested in the effect of
electromagnetic radiation on both bacterial and mammalian cells when E. coli was incubated
in a growth chamber with a set of platinum electrodes (which were considered inert), the
electrical field resulted in morphological changes to the E. coli [14,60–62]. Palladium ions
(Pd2+) can inhibit enzyme function in eukaryotic cells and are known to inhibit creatine
kinase, succinate dehydrogenase and other essential enzymatic processes [63]. In 2014,
it was determined that concentrations as low as ca. 10−9 M of Pd2+ ions resulted in the
inhibition of S. aureus growth after 24 h exposure [64]. The results presented in the current
study suggests the utilization of graphene foam in combination with specific metal ions
may have the potential to be used as part of a surface coating or wound dressing. Further
research is required to potentially develop metal ion/graphene foam surface coatings,
such as cytotoxic effects on mammalian cells and an enhanced understanding towards the
precise mechanisms of action of metal ions. However, the use of metal ions/graphene foams
in combination could reduce the risk of infection and the development of antimicrobial
resistance generation [13,65].
5. Conclusions
The antimicrobial activity of six metal ions, silver, gold, palladium, platinum, zinc
and gallium were evaluated against susceptible and resistant bacterial strains, S. aureus,
A. baumannii, K. pneumoniae and P. aeruginosa. Furthermore, the metal ions were tested
individually and in the presence of graphene foam (the metals were impregnated into
the graphene surface via a drop cast method) to determine if this potentiated the antimi-
crobial activity observed. Ionic gold, palladium and platinum demonstrated the greatest
antimicrobial activity against the susceptible and resistant strains. The combination of
graphene foam with palladium ions resulted in synergistic antimicrobial activity against
the resistant bacterial strains. Scanning electron microscopy (SEM) showed damage to the
cellular ultrastructure when the bacterial strains were incubated upon the graphene foam
alone. This study suggests that specific metal ions used in combination with graphene
foam against specific bacterial strains (with different antibiotic-resistant profiles), could
present a potential synergistic therapeutic option to treat AMR bacteria. Such combinations
could potentially be used in a multitude of applications for example, wound dressings or
surface coatings, effectively reducing wound infection and the transmission of common
healthcare-acquired infections (HAIs).
Supplementary Materials: The following are available online at https://www.mdpi.com/2079-641
2/11/3/352/s1, Table S1: Clinical Breakpoints determined by disc diffusion assays, data obtained
via The European Committee on Antimicrobial Susceptibility Testing (EUCAST) valid from 1 January
2021 [33]. Antibiotics not classified by EUCAST have been omitted from this table. Abbreviations:
ND; not determined.
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